Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging therapeutic targets for the treatment of malignant rhabdoid tumors
Karolina Nemes, Michael C. Frühwald
Expert Opinion on Therapeutic Targets (2018) Vol. 22, Iss. 4, pp. 365-379
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration
Hye-Jung E. Chun, Pascal D. Johann, Katy Milne, et al.
Cell Reports (2019) Vol. 29, Iss. 8, pp. 2338-2354.e7
Open Access | Times Cited: 92
Polo-Like Kinase 4’s Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy
Xiaoyang Zhang, Cheng Wei, Hao Liang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 47
B7–H3 as a Prognostic Biomarker and Therapeutic Target in Pediatric central nervous system Tumors
Uday Bhanu Maachani, Umberto Tosi, David J. Pisapia, et al.
Translational Oncology (2019) Vol. 13, Iss. 2, pp. 365-371
Open Access | Times Cited: 48
Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities
Krystal A. Orlando, Vinh Nguyen, Jesse R. Raab, et al.
Expert Review of Anticancer Therapy (2019) Vol. 19, Iss. 5, pp. 375-391
Open Access | Times Cited: 45
Rhabdoid Tumor Predisposition Syndrome: From Clinical Suspicion to General Management
Giada Del Baldo, Roberto Carta, Iside Alessi, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 35
Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitors
Cinzia Lanzi, Noemi Arrighetti, Sandro Pasquali, et al.
Biochemical Pharmacology (2023) Vol. 215, pp. 115727-115727
Closed Access | Times Cited: 13
Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer
Amreena Suri, Anders W. Bailey, Maurício T. Tavares, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2112-2112
Open Access | Times Cited: 41
Human Endogenous Retroviruses as Gene Expression Regulators: Insights from Animal Models into Human Diseases
Serpen Durnaoglu, Sun-Kyung Lee, Joohong Ahnn
Molecules and Cells (2021) Vol. 44, Iss. 12, pp. 861-878
Open Access | Times Cited: 31
Therapeutic Targeting of EZH2 and BET BRD4 in Pediatric Rhabdoid Tumors
Yukitomo Ishi, Yongzhan Zhang, Ali Zhang, et al.
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 5, pp. 715-726
Open Access | Times Cited: 19
Gem-TIP as a salvage therapy for pediatric extracranial malignant rhabdoid tumors: insights from a retrospective case series
Jian Li, Lulu He, Tianxing Hu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
SMARCB1 Deficiency as a Driver of the Hallmarks of Cancer in Rhabdoid Tumours: Novel Insights into Dysregulated Energy Metabolism, Emerging Targets, and Ongoing Clinical Trials
Abdul L. Shakerdi, Graham P. Pidgeon
Metabolites (2025) Vol. 15, Iss. 5, pp. 304-304
Open Access
Case-based review: atypical teratoid/rhabdoid tumor
Cody L. Nesvick, Amulya A. Nageswara Rao, Aditya Raghunathan, et al.
Neuro-Oncology Practice (2018) Vol. 6, Iss. 3, pp. 163-178
Open Access | Times Cited: 32
Translational genomics of malignant rhabdoid tumours: Current impact and future possibilities
Martina Finetti, Yura Grabovska, Simon Bailey, et al.
Seminars in Cancer Biology (2020) Vol. 61, pp. 30-41
Closed Access | Times Cited: 26
Clinical and genetic risk factors define two risk groups of extracranial malignant rhabdoid tumours (eMRT/RTK)
Karolina Nemes, Susanne Bens, D. Yu. Kachanov, et al.
European Journal of Cancer (2020) Vol. 142, pp. 112-122
Closed Access | Times Cited: 22
SMARCB1 deletion in atypical teratoid rhabdoid tumors results in human endogenous retrovirus K (HML-2) expression
Tara T. Doucet-O’Hare, Brianna Disanza, Catherine DeMarino, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 19
Methylation Drivers and Prognostic Implications in Sinonasal Poorly Differentiated Carcinomas
Laura Libera, Giorgia Ottini, Nora Sahnane, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 5030-5030
Open Access | Times Cited: 17
Novel Biomarkers in Sinonasal Cancers: from Bench to Bedside
Matt Lechner, Jacklyn Liu, Valerie J. Lund
Current Oncology Reports (2020) Vol. 22, Iss. 10
Open Access | Times Cited: 17
Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations. Spanish Group for Sarcoma research (GEIS –GROUP). Part II
Javier Martínez‐Trufero, Josefina Cruz Jurado, Carmen Nieves Hernández-León, et al.
Cancer Treatment Reviews (2021) Vol. 99, pp. 102260-102260
Closed Access | Times Cited: 15
Rare Hereditary Gynecological Cancer Syndromes
Takafumi Watanabe, Shu Soeda, Yuta Endo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1563-1563
Open Access | Times Cited: 10
The Swedish childhood tumor biobank: systematic collection and molecular characterization of all pediatric CNS and other solid tumors in Sweden
Teresita Díaz de Ståhl, Alia Shamikh, Markus Mayrhofer, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Review on Pediatric Malignant Focal Liver Lesions with Imaging Evaluation: Part II
Yi Dong, Andrius Čekuolis, Dagmar Schreiber-Dietrich, et al.
Diagnostics (2023) Vol. 13, Iss. 24, pp. 3659-3659
Open Access | Times Cited: 6
Pediatric Renal Tumors
Amy Treece
Surgical pathology clinics (2020) Vol. 13, Iss. 4, pp. 695-718
Closed Access | Times Cited: 13
Clinical evidence for a biological effect of epigenetically active decitabine in relapsed or progressive rhabdoid tumors
Mona Steinbügl, Karolina Nemes, Pascal D. Johann, et al.
Pediatric Blood & Cancer (2021) Vol. 68, Iss. 12
Open Access | Times Cited: 12
A Systematic Review and Meta-Analysis of Malignant Rhabdoid and Small Cell Undifferentiated Liver Tumors: A Rational for a Uniform Classification
Juri Fuchs, Anastasia Murtha-Lemekhova, M. Keßler, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 272-272
Open Access | Times Cited: 8
Malignant rhabdoid tumor of the liver in a middle-aged woman: a case report and literature review
Haikun Ye, Zirong Liu, Yamin Zhang
BMC Gastroenterology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top